• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Enoxaparin Superior to Unfractionated Heparin for STEMI at 12 months Follow Up: ExTRACT-TIMI 25 Trial

  • — 3 Sep, 2007
AudioMedica News
AudioMedica News
Enoxaparin Superior to Unfractionated Heparin for STEMI at 12 months Follow Up: ExTRACT-TIMI 25 Trial
Enoxaparin Superior to Unfractionated Heparin for STEMI at 12 months Follow Up: ExTRACT-TIMI 25 Trial
00:00 /
RSS Feed
Share
Link
Embed
David Morrow
David Morrow

REFERENCE: Abstract 1027, Clinical Trial Update I, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
DAVID MORROW, Brigham and Women’s Hospital, Boston
Further data to support the use of enoxaparin has come out of the latest update from the ExTRACT-TIMI 25 study. It shows at 12 months follow up, that the benefits of enoxaparin are durable and still superior to unfractionated heparin for patients with ST elevation myocardial infarction undergoing fibrinolytic therapy. Sarah Maxwell interviewed David Morrow at the Vienna meeting.

[audio:https://www.audiomedica.com/podcasting/cardio/070903_DavidMorrowPODCAST.mp3]

You may also like...

  • Eptifibatide After PCI: Brief Infusion Is Just As Good Eptifibatide After PCI: Brief Infusion Is Just As Good 5 Nov, 2007
  • LDL-How Low? LDL-How Low? 4 Sep, 2008
  • PREAMI: Perindopril Improves Remodelling in Older Patients with Acute Myocardial Infarction PREAMI: Perindopril Improves Remodelling in Older Patients with Acute Myocardial Infarction 12 Sep, 2005
  • Raw Deal for European Women with Coronary Artery Disease Raw Deal for European Women with Coronary Artery Disease 12 Sep, 2005
  • Previous story BNP Test: Key Diagnostic Step for Heart Failure (PEP Study)
  • Next story Drug Eluting Stent Shows Great Benefit in Chronic Total Occlusions
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • New Front Line Standard for Older Patients with Chronic…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
    • Microbiome Diversity Key To Survival After Allogeneic…
  • Home
  • Cardiovascular
  • Enoxaparin Superior to Unfractionated Heparin for STEMI at 12 months Follow Up: ExTRACT-TIMI 25 Trial

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.